The trajectory of Sildenafil presents a challenging picture for those considering investment. While the initial introduction generated massive returns, the lapse of its patent opened the floodgates to cheaper https://bookmarketmaven.com/story22512462/sildenafil-and-big-pharma-a-precarious-opportunity